HIMS Stock: Navigating GLP-1 Scrutiny and Market Resilience
Hims & Hers stock shows resilience despite JPMorgan stake cuts and FDA scrutiny over GLP-1 drugs, highlighting telehealths evolving landscape.
Hims & Hers stock shows resilience despite JPMorgan stake cuts and FDA scrutiny over GLP-1 drugs, highlighting telehealths evolving landscape.